Day: October 3, 2017

Published on: October 03, 2017 at 10:00AM Conditions:   Colorectal Adenocarcinoma;   RAS Wild Type;   Stage III Colorectal Cancer AJCC v7;   Stage IIIA Colorectal Cancer AJCC v7;   Stage IIIB Colorectal Cancer AJCC v7;   Stage IIIC Colorectal Cancer AJCC v7;...

Published on: October 03, 2017 at 10:00AM Conditions:   Colorectal Adenocarcinoma;   RAS Wild Type;   Stage III Colorectal Cancer AJCC v7;   Stage IIIA Colorectal Cancer AJCC v7;   Stage IIIB Colorectal Cancer AJCC v7;   Stage IIIC Colorectal Cancer AJCC v7;...

Published on: October 03, 2017 at 10:00AM Conditions:   Breast Cancer Lymphedema;   Shoulder InjuryInterventions:   Other: Fulfillment of a preventive programme;   Other: No fulfillment of a preventive programmeSponsors:   Hospital Universitario 12 de Octubre;   University of Castilla-La Mancha;...

Published on: October 03, 2017 at 10:00AM Condition:   Thyroid CancerIntervention:   Behavioral: QuestionnairesSponsor:   Memorial Sloan Kettering Cancer CenterRecruiting http://ift.tt/2hLh27J

Published on: October 03, 2017 at 10:00AM Condition:   Rectal CancerInterventions:   Drug: Avelumab;   Drug: 5 Fluorouracil;   Drug: Capecitabine Pill;   Radiation: Radiotherapy;   Procedure: Surgical ResectionSponsor:...

Published on: October 03, 2017 at 10:00AM Conditions:   Atypical Hyperplasia;   Endometrial Intraepithelial Neoplasia;   Grade 1 Endometrial Endometrioid AdenocarcinomaInterventions:   Drug: Exemestane;   Other: Laboratory Biomarker AnalysisSponsor:   National Cancer Institute (NCI)Not...

Published on: October 03, 2017 at 10:00AM Condition:   Thyroid CancerInterventions:   Drug: Apatinib;   Radiation: Intensity modulated radiation therapySponsor:   Xiayun He, MDRecruiting http://ift.tt/2knhnOW

Published on: October 03, 2017 at 10:00AM Condition:   Prostate CancerInterventions:   Drug: ARRx;   Drug: PembrolizumabSponsor:   University of Michigan Cancer CenterNot yet recruiting http://ift.tt/2wwAkAa

Published on: October 03, 2017 at 10:00AM Condition:   Elderly Patients Affected by Solid MalignancyIntervention:   Other: QuestionnairesSponsors:   AUSL ROMAGNA;   European Society of Surgical Oncology;   SIOG (International Society...

Published on: October 03, 2017 at 10:00AM Conditions:   Rectal Adenocarcinoma;   Stage III Rectal Cancer AJCC v7;   Stage IIIA Rectal Cancer AJCC v7;   Stage IIIB Rectal Cancer AJCC v7;   Stage IIIC Rectal Cancer AJCC v7;   Stage IV Rectal Cancer AJCC v7;...

Published on: October 03, 2017 at 10:00AM Condition:   Non-Small Cell Lung CancerIntervention:   Other: Will look for immune infiltrationSponsors:   University Hospital of North Norway;   Norwegian Cancer Society;   Northern Health Authority;   St. Olavs Hospital;...

Published on: October 03, 2017 at 10:00AM Condition:   Metastatic CancerInterventions:   Drug: Non Chemotherapy;   Drug: Chemotherapy and target therapy;   Drug: Chinese herb medicineSponsor:   Haining Health-Coming Biotech Co., Ltd.Recruiting http://ift.tt/2klUz1F

Published on: October 03, 2017 at 10:00AM Conditions:   Colorectal Adenocarcinoma;   RAS Wild Type;   Stage III Colorectal Cancer AJCC v7;   Stage IIIA Colorectal Cancer AJCC v7;   Stage IIIB Colorectal Cancer AJCC v7;   Stage IIIC Colorectal Cancer AJCC v7;...

Published on: October 03, 2017 at 10:00AM Conditions:   Colorectal Adenocarcinoma;   RAS Wild Type;   Stage III Colorectal Cancer AJCC v7;   Stage IIIA Colorectal Cancer AJCC v7;   Stage IIIB Colorectal Cancer AJCC v7;   Stage IIIC Colorectal Cancer AJCC v7;...